Evaluation of Alendronate Efficacy on Bone Mineral Density in Thalassemic Patients

Evaluation of Alendronate Efficacy on Bone Mineral Density in Thalassemic Patients

Show other versions (1)

Introduction: Thalassemia is the most common genetic disorder, affecting around 200 million people worldwide. The etiology of this bone disease is multifactorial. Seemingly, in the setting of increased bone turnover which manifests by increased bone resorption and remodeling; bone density decreases....

Full description

Bibliographic Details
Main Authors: Fatemeh Shirani, Mahin lashkari, Ali Shahriari Ahmadi, Mohsen Arabi, Nastaran Asefi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2012-10-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Thalassaemia
Osteoporosis
BMD
Alendronate
Online Access:http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/346/353

Similar Items

Similar Items